Rafferty Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-102,397
| Closed | -$6.97M | – | 1177 |
|
|
2022
Q3 | $6.97M | Sell |
102,397
-69,291
| -40% | -$4.72M | 0.07% | 223 |
|
|
2022
Q2 | $5.49M | Sell |
171,688
-23,605
| -12% | -$754K | 0.05% | 266 |
|
|
2022
Q1 | $6.77M | Buy |
195,293
+1,429
| +0.7% | +$49.5K | 0.04% | 281 |
|
|
2021
Q4 | $5.67M | Buy |
193,864
+78,480
| +68% | +$2.3M | 0.03% | 333 |
|
|
2021
Q3 | $2.94M | Buy |
115,384
+51,200
| +80% | +$1.3M | 0.02% | 489 |
|
|
2021
Q2 | $2.25M | Sell |
64,184
-11,492
| -15% | -$402K | 0.01% | 654 |
|
|
2021
Q1 | $3.08M | Buy |
75,676
+52,698
| +229% | +$2.15M | 0.02% | 468 |
|
|
2020
Q4 | $995K | Sell |
22,978
-14,629
| -39% | -$633K | 0.01% | 496 |
|
|
2020
Q3 | $2.07M | Buy |
37,607
+22,359
| +147% | +$1.23M | 0.03% | 407 |
|
|
2020
Q2 | $963K | Buy |
15,248
+9,239
| +154% | +$583K | 0.01% | 559 |
|
|
2020
Q1 | $307K | Sell |
6,009
-45,020
| -88% | -$2.3M | 0.01% | 436 |
|
|
2019
Q4 | $4.06M | Sell |
51,029
-68,944
| -57% | -$5.48M | 0.06% | 161 |
|
|
2019
Q3 | $5.82M | Buy |
119,973
+28,385
| +31% | +$1.38M | 0.09% | 135 |
|
|
2019
Q2 | $4.82M | Sell |
91,588
-7,561
| -8% | -$398K | 0.08% | 172 |
|
|
2019
Q1 | $5.25M | Buy |
+99,149
| New | +$5.25M | 0.08% | 130 |
|